A phase II study of irinotecan in children with relapsed or refractory neuroblastoma : a European cooperation of the Societe Francaise d'Oncologie Pediatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)
収録刊行物
-
- Eur J Cancer
-
Eur J Cancer 44 2453-2460, 2008